Last Price
0.004
Today's Change
+0.001 (33.33%)
Day's Change
0.003 - 0.004
Trading Volume
3,200,201
Market Cap
20 Million
Shares Outstanding
5 Billion
Avg Volume
3,758,567
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
0.00
EPS
0.00
Earnings Announcement
30-Aug-2024
Previous Close
0.00
Open
0.00
Day's Range
0.003 - 0.004
Year Range
0.002 - 0.008
Trading Volume
3,200,201
1 Day Change
33.33%
5 Day Change
0.00%
1 Month Change
33.33%
3 Month Change
0.00%
6 Month Change
-20.00%
Ytd Change
-20.00%
1 Year Change
-20.00%
3 Year Change
-71.43%
5 Year Change
-73.33%
10 Year Change
-93.34%
Max Change
-98.68%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.